Medical Health & Life Science Research News

Detailed examination of the Global influenza vaccines market worth USD 4.34 billion in 2021

Influenza Vaccines Market by Vaccine Type (Quadrivalent, Trivalent), by Route of Administration (Intramuscular, Intravenous, Others), and by Geography - Global Forecast to 2021


The report on “Influenza Vaccines Market Make an Inquiry about this news by Vaccine Type (Quadrivalent, Trivalent), by Route of Administration (Intramuscular, Intravenous, Others), and by Geography – Global Forecasts to 2021”. The global influenza vaccines market has been estimated to be worth USD 4.65 Billion in 2016 and is projected to be valued at USD 8.81 Billion by the end of 2021, registering a CAGR of 13.6% during forecast period.

Increasing pandemic outbreak, growing geriatric population, and rising affordability of flu vaccines in emerging economies are the key factors bolstering the growth of the influenza vaccines market.

Based on Vaccine Type, Quadrivalent Vaccines is projected to be the fastest growing segment

The specificity as well as the effectiveness of quadrivalent influenza vaccines and increasing consumer demand for quadrivalent flu vaccines are the key factors propelling the growth of quadrivalent flu vaccines market.